Novakand Pharma AB (publ) (LARK) — Net Asset Quality Index
Novakand Pharma AB (publ) (LARK) has a Net Asset Quality Index of 98.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr57.56 Million minus total liabilities of Skr846.00K yields net assets of Skr56.71 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Novakand Pharma AB (publ) cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Novakand Pharma AB (publ) Net Asset Quality Index Over Time (2012–2025)
This chart shows how Novakand Pharma AB (publ)'s Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 98.5%, representing net assets of Skr56.71 Million against total assets of Skr57.56 Million SEK. See LARK net asset value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Novakand Pharma AB (publ) (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Novakand Pharma AB (publ) from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Novakand Pharma AB (publ) market cap and net worth.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.8% | Skr55.49 Million | Skr56.73 Million | Skr1.24 Million | ▲ +3.5 pp |
| 2024 | 94.3% | Skr71.58 Million | Skr75.88 Million | Skr4.30 Million | ▼ -2.2 pp |
| 2023 | 96.6% | Skr116.46 Million | Skr120.61 Million | Skr4.16 Million | ▲ +0.4 pp |
| 2022 | 96.1% | Skr152.12 Million | Skr158.22 Million | Skr6.10 Million | ▲ +0.9 pp |
| 2021 | 95.2% | Skr158.28 Million | Skr166.22 Million | Skr7.94 Million | ▲ +5.3 pp |
| 2020 | 90.0% | Skr71.43 Million | Skr79.41 Million | Skr7.98 Million | ▲ +43.6 pp |
| 2019 | 46.3% | Skr20.30 Million | Skr43.82 Million | Skr23.51 Million | ▼ -11.9 pp |
| 2018 | 58.3% | Skr20.46 Million | Skr35.12 Million | Skr14.66 Million | ▼ -21.8 pp |
| 2017 | 80.0% | Skr6.51 Million | Skr8.14 Million | Skr1.63 Million | ▼ -3.4 pp |
| 2016 | 83.4% | Skr4.08 Million | Skr4.89 Million | Skr809.66K | ▼ -10.2 pp |
| 2015 | 93.7% | Skr10.27 Million | Skr10.96 Million | Skr691.73K | ▲ +3.0 pp |
| 2014 | 90.7% | Skr5.67 Million | Skr6.25 Million | Skr582.04K | ▼ -2.9 pp |
| 2013 | 93.6% | Skr598.60K | Skr639.58K | Skr40.98K | ▲ +43.5 pp |
| 2012 | 50.1% | Skr298.09K | Skr594.67K | Skr296.58K | — |